510(k) Report

FDA applicant

Rapid Diagnostics, Inc.

Burlingame, CA4 decisions1998–20040 recalls

FDA records 4 decisions for Rapid Diagnostics, Inc. (Burlingame, CA) from 1998 to 2004: 4 510(k) clearances. Most are in product codes DKZ (Enzyme Immunoassay, Amphetamine) and JHI (Visual, Pregnancy Hcg, Prescription Use). No recall is linked to its devices.

Data to Oct 25, 2026 (FDA decisions) Oct 12, 2026 (recalls) refreshed weekly, last Nov 3, 2026

FIG. A — Illustration, clinical toxicology panel, where it files most

How often FDA has decided Rapid Diagnostics, Inc.’s devices, and how often a recall has named them.

FDA decisions per year

No FDA decision for Rapid Diagnostics, Inc. since 2007.

Recalls per year

No recall linked to its devices since 2007.

FIG. 1 — Rapid Diagnostics, Inc. by year, 2007–2026Sources: FDA decision databases, recall and enforcement reports · Data through Oct 25, 2026

Planning a device like Rapid Diagnostics, Inc.’s? A 510(k) Report ranks candidate predicates for your device by lineage, citations and recall history, with the review-time outlook.

See the 510(k) Report

Other applicant names beginning “Rapid”

FDA records each applicant name separately; these may or may not be the same firm.